BROKER RATINGS: Berenberg says buy Shaftesbury, Capital & Counties
BROKER RATINGS: Berenberg says buy Shaftesbury, Capital & Counties
Read moreMon, 01st Feb 2021 13:44
BROKER RATINGS: Berenberg says buy Shaftesbury, Capital & Counties
Read more(Sharecast News) - Pharmaceutical company Clinigen has agreed the disposal of its non-core UK specials manufacturing and aseptic compounding business to Target Healthcare for up to £7.75m.
Read moreClinigen to sell non-core UK Specials business for GBP7.8 million
Read moreBROKER RATINGS: HSBC upgrades airlines Ryanair, Wizz and easyJet
Read moreLONDON MARKET MIDDAY: Hesitation before risk events; Clinigen down 25%
Read moreCORRECT: Clinigen slides 25% as Covid hits other hospital treatments
Read moreAIM WINNERS & LOSERS: Clinigen shares dive as earnings outlook lowered
Read moreBROKER RATINGS: Smith & Nephew gets upgrade while M&G receives cut
Read moreTOP NEWS: Clinigen slides 20% as Covid hits other hospital treatments
Read more(Sharecast News) - Pharmaceutical firm Clinigen said on Wednesday that while net revenues were still expected to be in line with both guidance and expectations, full-year adjusted underlying earnings were now projected to be within the range of £114.0m and £117.0m due to a decrease in revenues from its products division.
Read moreLONDON MARKET OPEN: Stocks hover with sights set on US inflation
Read moreLONDON MARKET PRE-OPEN: UK competition regulator probes BA and Ryanair
Read more(Sharecast News) - Touchstone Exploration: Canaccord downgrades to speculative buy with a target price of 140p.
Read moreClinigen to supply Erwinase in UK in "milestone" with PBL partnership
Read more